Omforro (midazolam)
- Region
- 🇪🇺 EU
- Active substance
- midazolam
- Company
- Regulatory Pharma Net S.r.l.
- Status
- Application withdrawn
- Therapeutic area
- Conscious Sedation; Anesthesia
- Application
- EMEA/H/C/005657
- ATC
- N05CD08
- Official record
- www.ema.europa.eu
Indication
Conscious sedation before and during diagnostic or therapeutic procedures with or without local anaesthesia and premedication before induction of anaesthesia.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Tuzodi Application withdrawn · Regulatory Pharma Net S.r.l.
- 🇪🇺 Buccolam Authorised · Neuraxpharm Pharmaceuticals S.L.
Follow Omforro
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.